Element Materials Technology Acquires Arch Sciences Group

July 20, 2021

Element Materials Technology, a London-headquartered testing, inspection and certification provider, has acquired Arch Sciences Group, a specialist analytical services and laboratory solutions provider to the pharmaceuticals sector. The deal (which sees Limerston Capital exit its investment in Arch) brings Element a team of ~170 employees across five locations and establishes Element's entry into the European pharmaceutical market, expanding its life sciences capabilities.

Buyers
Element Materials Technology
Targets
Arch Sciences Group
Sellers
Limerston Capital
Industry
Pharmaceuticals
Location
England, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.